Small Cap Wrap: Month: December 2016

AIM Breakfast - Archive

22nd December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

Read More...

21st December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

 

Read More...

20th December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

 

Read More...

19th December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

Read More...

16th December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

Read More...

15th December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

 

Read More...

14th December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Read More...

13th December 2016

Ultimate Products—The Telegraph reports Jim McCarthy, former chief of Poundland has been appointed Chairman of Ultimate Products ahead of a £100m listing in H1 2017. Ultimate Products owns the Beldray cleaning brand and the licence to sell Russell Hobbs and Salter electrical products in the UK.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.9m. Target date 14 Dec. Expected market cap £15m, with issue price of 167p.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

 

Read More...

12th December 2016

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.9m. Target date 14 Dec. Expected market cap £15m, with issue price of 167p.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

 

Read More...

9th December 2016

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

 

Read More...

8th December 2016

Creo Medical group—Schedule 1 update.. £20m raise. Expected market cap £61.2m, admission expected 9 December.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

 

Read More...

7th December 2016

Creo Medical group—Schedule 1 update.. £20m raise. Expected market cap £61.2m, admission expected 9 December.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

 

Read More...

5th December 2016

Big Sofa Technologies— Schedule 1 from the b2b technology company providing video analytics at an enterprise level. Seeking to complete RTO of unlisted HubCo investments. Raising £6.1m. Target date 19 December.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Creo Medical Group – UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. £20m to be raised on Admission with anticipated market cap of £61.2m

Read More...

2nd December 2016

Big Sofa Technologies— Schedule 1 from the b2b technology company providing video analytics at an enterprise level. Seeking to complete RTO of unlisted HubCo investments. Raising £6.1m. Target date 19 December.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Creo Medical Group – UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

 

Read More...

1st December 2016

Big Sofa Technologies— Schedule 1 from the b2b technology company providing video analytics at an enterprise level. Seeking to complete RTO of unlisted HubCo investments. Raising £6.1m. Target date 19 December.

ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m.

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Creo Medical Group – UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

 

Read More...

30th November 2016

Asia Pacific Investment Partner  – The research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Diversified Oil & Gas – Schedule One now out. $60m to be raised. Expected admission 6 December.

Creo Medical Group – UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

 

Read More...

29th November 2016

Asia Pacific Investment Partner  – the research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December

RM Secured Direct Lending  –  The secured direct lending fund  intends to float on the Main Market on 15 December raising up to £100m

Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December.

Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

 

Read More...

28th November 2016

Warpaint London—Schedule one update. Raising £2.5m at 97p. Expected mkt cap £62.6m vs revenues of £22.3m

Walls & Futures REIT — Has raised £1m at £1 to acquire, refurbish or develop residential properties in the UK . Due to arrive on ISDX on 29 November

Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December.

Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

 

Read More...

25th November 2016

i3 Energy Investment—According to its investor Glenwick (GWIK.L) i3 will seek an AIM admission once its license has been approved by the UK Oil & Gas Authority

Walls & Futures REIT — Has raised £1m at £1 to acquire, refurbish or develop residential properties in the UK . Due to arrive on ISDX on 29 November

Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December.

Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

Read More...

07th December 2016

 Crossword brings in the money

TMT on a roll

Toople Hires

Ace Liberty & Stone (ISDX:ALSP 4p/£39.3m)*

Ace Liberty and Stone, the active property investment Company, capitalising on commercial property investment opportunities across the UK, announced that the Company has drawn down a secured loan of £13.75m.  The facility is provided by Lloyds Bank Commercial Banking and has been used to complete the purchase of 1-5 Upper Market Square, Hanley (announced 5th October 2016), as well as to refinance properties owned at Marsh Mills, Plymouth; Shildon House, Gateshead; Bridge House, Dudley; Fawcett House, Sunderland and Hillcrest House, Leeds. The Company also announced that in 2016 Daniel Waylett, a shareholder, agreed to purchase the entire share capital of Ace (Sloane) Limited, the 100 percent subsidiary of the Company, which owns Colebrook Court, Sloane Avenue. The consideration totalled £1.55m for the disposal. The purchase of Colebrook Court was announced on 17 April 2016 for £1.5m in issue of new shares. The sale will release cash for further investment in new commercial properties.

Capital for Colleagues (ISDX:CFCP 62.5p/£6m)

Capital for Colleagues, the investment vehicle focused on opportunities in the Employee Owned Business sector, announced an update regarding its existing investee Company, Hire & Supplies Limited (H&S), which is engaged in tool and plant sale and rental from branches in the west of Scotland.  The £0.2m fixed term loan from Capital for Colleagues to H&S and the 100,000 Convertible Preference Shares of H&S held by the Company have been redeemed through the allotment to the Company of ‘A’ Ordinary Shares of £1 each in H&S with a value of £0.3m. The ‘A’ Ordinary Shares have preferential rights with respect to ongoing dividends and with respect to capital value in the event of the occurrence of certain exit events.

 

Crossword Cybersecurity (ISDX:CCS 195p/£6.1m)*

Crossword Cybersecurity, the technology commercialisation Company focusing exclusively on the cyber security sector, announced that the Company has successfully raised gross proceeds totalling £1.4m at a Placing Price of £1.90 per share. As part of the Subscription, Tom Ilube, Chief Executive Officer and Dr David Secher, Non-Executive Director, agreed to subscribe for new Ordinary Shares to raise proceeds of £260,995 as further detailed below.

Digital Barriers (LON:DGB 36.5p/£60.68m)

Digital Barriers, the specialist provider of visually intelligent solutions to the global surveillance, security and safety markets, announced that it has secured contracts across EMEA and APAC. The total value of these contracts is approximately £1.75m and includes: First major contract win for body-worn video surveillance, the multi-year contract, with a major Asia Pacific law enforcement agency, is valued at approximately £1.0m; €0.35m award for immediate delivery under multi-year counter terrorism framework agreement for the Group’s facial recognition solution with European Ministry of Defence worth up to €3.5m and initial contract valued at £0.4m with a flagship Middle East government agency for EdgeVis Live surveillance solutions to enhance operational capabilities.

.

Physiomics (LON:PYC 0.02p/£1.23m)*

Physiomics, the Oxford based systems biology Company, announced that it has been notified of Innovate UK’s intention to award the Company a grant for its proposed project “Decision Support Systems For Stratified Cancer Treatment”, as part of Innovate UK’s Biomedical Catalyst 2016 Feasibility Study Competition, co-funded by Scottish Enterprise and the Medical Research Council. In line with the Company’s strategic objective to explore the personalised medicine market set out in the full year results RNS published on the 27th October 2016, the objective of the project is to create a prototype decision support system to improve cancer care by helping medical professionals make treatment decisions based on patient specific data. A Biomedical Catalyst Feasibility Study grant covers 70 percent of the costs of projects up to £0.2m in value.  The award of the grant, including the precise level of funding, remains subject to the submission of detailed project plans as well as a financial review by Innovate UK and the definitive award is likely to be made in Q1 2017.  Accordingly, whilst the directors are confident that the grant will be issued there can be no guarantee it will be, until the plans are approved. Further announcements will be made in due course. The Company also announced that it is now entitled to a payment from Sareum Holdings plc for a three month modelling project conducted by the Company in 2010 in support of Sareum’s cancer drug joint research program with The Institute of Cancer Research (ICR) and Cancer Research Technology Limited (CRT), as originally announced by RNS on 16th March 2010.

 

TMT Investments (LON:TMT $1.875/$52m)*

TMT Investments, the venture capital Company investing in high-growth, internet-based companies across a variety of core specialist sectors, announced that The Climate Corporation, a subsidiary of Monsanto Company, has acquired VitalFields, one of its portfolio companies. The acquisition by Monsanto represents the ninth profitable exit by TMT from its investment portfolio since its admission to AIM in December 2010. Incorporated in Tallinn, Estonia, WeatherMe OÜ, trading as VitalFields, simplifies the many farming tasks involved with spraying, fertilising and sowing thanks to its app and web interfaces. Examples of the multiple capabilities that VitalFields offers to farmers include plant disease and growth phase modelling (tracking climatic patterns and analysing farmer’s input to assess risks) and farm management functionality (from planning and managing farm activities to stock management and P&L reports). TMT originally invested €0.1m in the form of a convertible note in VitalFields in December 2013, which it subsequently converted into equity when VitalFields raised further capital in 2015.

 

Toople (LON:TOOP 5.25p/£5.62m)

Toople, a provider of bespoke telecom services to UK SMEs, announced the appointment of Mark Evans as Chief Operating Officer effective as of 21 November 2016. Mark has more than 14 years’ industry experience, having previously held senior positions at 02. He joined Toople shortly after the IPO and has been leading the Company’s digital omnichannel sales and contact centre strategy since launch. Mark will now lead the Toople customer engagement functions both from a people, software and channel marketing perspective, ensuring back office process is best in class and focusing on delivering a great customer experience to small businesses that is aligned to their needs. The Company also announced that having successfully delivered the integration of the Group’s proprietary bespoke telecoms platform, Merlin, into the business, Dave Breith has now come to the end of his consultancy agreement with Toople. Toople owns the full Intellectual Property Rights for this platform. Dave’s last day with the Company will be on 18 November 2016 .

Warpaint London (LON:W7L 131.75p/£83.58m)

Warpaint London, a specialist supplier of colour cosmetics and owner of the W7 brand, announced the admission of its ordinary shares to trading on the AIM of the London Stock Exchange. Dealings in the ordinary shares will commence at 8.00am under the ticker “W7L”. Oversubscribed placing raising gross proceeds of £23m with institutional and other investors, including Board Directors, at a placing price of 97 pence per ordinary share. Warpaint London has a market capitalisation of approximately £62.6m at the Placing Price. The Directors believe that the Admission to AIM will raise the Company’s profile, enhance W7’s brand awareness and provide investment to accelerate the growth of the business, as described in the Admission Document.